Drugs & Targets EMA adopts positive opinion for Keytruda + Inlyta as first-line for RCC August 02, 2019Vol.45 No.31
Trials & Tribulations Barriers to clinical trial enrollmentPart I of a two-part series August 02, 2019Vol.45 No.31By Daniel Wall, Stephanie Engelien and Adedayo A. Onitilo
In Brief ACS CAN report: Texas must improve cancer-related public policies August 02, 2019Vol.45 No.31
In Brief TCR2 Therapeutics partners with NCI for phase I/II trial of TC-210 August 02, 2019Vol.45 No.31
MD Anderson retains top spot on U.S. News rankings; Johns Hopkins moves up to No. 4 August 02, 2019Vol.45 No.31By Matthew Bin Han Ong
Drugs & Targets Predictive Oncology, UPMC partner to establish AI approach to ovarian cancer July 26, 2019Vol.45 No.30
Clinical Roundup Genomics of Drug Sensitivity in Cancer project releases results July 26, 2019Vol.45 No.30
